Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical program in cognitive impairment in adults with schizophrenia, showing primary and key secondary endpoints were not met.1–6 Overall, no statistically significant effects on cognition or functioning were observed in patients treated with iclepertin versus placebo at six months.1 All three trials demonstrated that iclepertin, a [...]
As a leader in neuroscience, Teva remains committed to helping address unmet needs in the treatment of schizophrenia through scientific and clinical advances that support optimal treatment options and decisions for patients and HCPs New data demonstrate switching to UZEDY at four weeks after the last dose of once-monthly RBP-7000 provided the most comparable pharmacokinetic (PK) profile based on relevant simulations, with comparable doses identified New ADVANCE survey findings highlight key patient-reported [...]
SEOUL, June 9 (Korea Bizwire) – Following the Gangnam Station murder last month, the government is planning to take more serious action against schizophrenia patients, including involuntary hospitalization. However, many of those suffering from mental disorders have pleaded that their illnesses do not make them potential criminals. The ‘Experts Debate for Countermeasures against Social Hatred [...]
SEOUL, May 23 (Korea Bizwire) – The case of a woman who was stabbed to death by a stranger last week was not a hate crime, but rather a crime induced by mental illness, authorities said on Sunday. Kim, a 34-year-old man, was arrested last Tuesday on suspicion of killing a 23-year-old woman in a [...]
SEOUL, Jun. 29 (Korea Bizwire) — Korean and American researchers have found a correlation between a group of genes that are known to trigger depression, schizophrenia and bipolar diseases. A team led by professor Lee Do-Heon at the Bio-Synergy Research Center and Dr. Kim Sang-Hyun at the Stanley Medical Research Institute (SMRI) said on June [...]